Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Biol Rep ; 49(3): 1721-1729, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34813001

ABSTRACT

BACKGROUND: Polycystic ovary syndrome (PCOS) is a metabolic disease that causes infertility due to anovulation in women in reproductive age. It is known that clomiphene citrate (CC) and tamoxifen citrate (TMX) induce ovulation in women with PCOS. In this study, we aimed to investigate the effects of CC and TMX on the autophagy pathway in PCOS. METHODS AND RESULTS: Experimental PCOS model was induced by letrozole (1 mg/kg) in rats by gavage for 21 days. After the last letrozole administration, rats were treated TMX (1 mg/kg) or CC (1 mg/kg) for 5 days. At the end of the experimental procedures, rats in all groups were sacrificed and ovarian tissues were removed. It was observed that mRNA and protein expressions of LC3-II were significantly higher in TMX and CC groups than control and PCOS groups (p < 0.05), while mRNA and protein expressions of mTOR in TMX and CC groups were found significantly lower than control and PCOS groups (p < 0.05). CONCLUSIONS: In conclusion, present study suggests that TMX and CC induce autophagy in ovaries with PCOS. Autophagy is a promising target for understanding pathophysiology of this disease and for developing more effective and safe new protocols for the treatment of PCOS-related anovulation.


Subject(s)
Infertility, Female , Polycystic Ovary Syndrome , Animals , Autophagy , Clomiphene/pharmacology , Female , Fertility Agents, Female/pharmacology , Humans , Infertility, Female/etiology , Microtubule-Associated Proteins , Ovulation Induction/methods , Polycystic Ovary Syndrome/chemically induced , Polycystic Ovary Syndrome/drug therapy , Polycystic Ovary Syndrome/genetics , Rats , TOR Serine-Threonine Kinases/genetics , Tamoxifen/pharmacology
2.
Biomed Pharmacother ; 87: 240-246, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28061407

ABSTRACT

Diabetes is a multisystem disorder and its effects are observed on the reproductive system. One of the main causes of testicular tissue damage is diabetes-induced overproduction of reactive oxygen species and glycated end products. The main objectives of this study were to investigate the possible effects of agomelatine (AG) and gallic acid (GA) in suppressing oxidative stress in Type I diabetes induced testicular damage. A total of 28 adult male rats were included in the study. Diabetes was induced by intraperitoneal injection of streptozocin (STZ, 55mg/kg) to 21 rats, which were then randomly assigned to 3 groups; 1mL saline solution was given to the diabetes+saline group by oral gavage, 20mg/kg/day oral AG was given to the diabetes+AG group, and 20mg/kg/day oral GA was given to the diabetes+GA group for 4 weeks. Tumor necrosis factor α (TNFα), nitric oxide synthase 2 (NOS2), fibronectin and vascular endothelial growth factor (VEGF) were used for the investigation of inflammation, fibrosis and vascular structures. The terminal-deoxynucleoitidyl-transferase mediated nick end-labeling assay (TUNEL) was used to detect apoptosis. Testicular tissue total antioxidant capacity values were tested by biochemical analysis. AG treatment showed an improvement on biochemical parameters and histopathological appearance on the rat testes. GA showed dose-related regenerative effects on biochemical parameters. Histologically, a minimal healing effect was determined on the testes damage. In conclusion, it was observed that AG is a potentially beneficial agent for reducing testicular damage by decreasing oxidative stress level. However, GA was seen to have a poor therapeutic effect.


Subject(s)
Acetamides/therapeutic use , Antioxidants/therapeutic use , Diabetes Mellitus, Type 1/metabolism , Gallic Acid/therapeutic use , Oxidative Stress/physiology , Testis/metabolism , Acetamides/pharmacology , Animals , Antioxidants/pharmacology , Diabetes Mellitus, Type 1/chemically induced , Diabetes Mellitus, Type 1/drug therapy , Gallic Acid/pharmacology , Lipid Peroxidation/drug effects , Lipid Peroxidation/physiology , Male , Oxidative Stress/drug effects , Random Allocation , Rats , Rats, Sprague-Dawley , Streptozocin , Testis/drug effects , Testis/pathology
3.
Braz Oral Res ; 302016.
Article in English | MEDLINE | ID: mdl-26981753

ABSTRACT

The aim of this study was to evaluate whether medium modification improves the odontogenic differentiation of human dental pulp stem cells (DPSC) in vitro and in vivo. DPSC isolated from human impacted third molar teeth were analysed for clusters of differentiation with flow cytometry. Odontogenic differentiation was stimulated by medium modification with the addition of bone morphogenetic protein 2 (BMP2). The expression of dentin sialophosphoprotein, dentin matrix protein 1, enamelysin/matrix metalloproteinase 20 and the phosphate-regulating gene with homologies to endopeptidases on the X chromosome of the cells were analysed with RT-PCR at 7, 14 and 21 days. Then, DPSC were transplanted on the back of immunocompromised mice via a hydroxyapatite tricalcium phosphate scaffold, and the structure of the formed tissue was investigated. The cells were identified as mesenchymal stem cells with a 98.3% CD73 and CD90 double-positive cell rate. The increase in mineralization capacity and expression of human enamel-dentin specific transcripts proportional to the culture period were determined after differentiation. Six weeks after transplantation, an osteo-dentin matrix was formed in the group in which odontogenic differentiation was stimulated, and the odontogenic characteristics of the matrix were confirmed by histological examination and RT-PCR analysis. Odontogenic differentiation of the isolated and characterized human DPSC was improved with medium modification by the addition of BMP2 in vitro and in vivo. The defined medium and applied technique have a potential use for forming reparative dentin in the future, but the effects of the method should be investigated in long-term studies.


Subject(s)
Bone Morphogenetic Protein 2/pharmacology , Cell Differentiation/drug effects , Culture Media/chemistry , Dental Pulp/cytology , Stem Cells/cytology , Actins/analysis , Adult , Animals , Bone Morphogenetic Protein 2/chemistry , Cell Differentiation/physiology , Cell Proliferation/drug effects , Cell Proliferation/physiology , Cells, Cultured , Extracellular Matrix Proteins/analysis , Flow Cytometry , Humans , Matrix Metalloproteinase 20/analysis , Mice , Odontogenesis/drug effects , Odontogenesis/physiology , PHEX Phosphate Regulating Neutral Endopeptidase/analysis , Phosphoproteins/analysis , Reproducibility of Results , Reverse Transcriptase Polymerase Chain Reaction , Sialoglycoproteins/analysis , Stem Cell Transplantation/methods , Time Factors , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...